Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goadsby

Showing results (701-710 of 916) with videos related to

Pageof 92
Sort By:
BMC Neurology|December 16, 2014
Enhancing cognitive-behavioural therapy for recurrent headache: design of a randomised controlled trialPaul R Martin, Sharon Mackenzie, Siavash Bandarian-Balooch, et al.
Cephalalgia : an International Journal of Headache|March 11, 2015
Is migraine a risk factor for pediatric stroke?Amy A Gelfand, Heather J Fullerton, Alice Jacobson, et al.
British Journal of Pharmacology|January 25, 2020
Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal painChristopher M Holton, Lauren C Strother, Isaac Dripps, et al.
Journal of Patient-Reported Outcomes|December 18, 2024
Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: post hoc analysis of the DELIVER trialPiero Barbanti, Susanne F Awad, Heather Rae-Espinoza, et al.
Headache|June 22, 2019
The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey StudyAmy A Gelfand, Dawn C Buse, Michael D Cabana, et al.
Cephalalgia : an International Journal of Headache|November 1, 1996
Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor geneD R Nyholt, R P Curtain, P T Gaffney, et al.
The Lancet. Neurology|August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trialPeter J Goadsby, David W Dodick, Jessica Ailani, et al.
Neurology|November 18, 2018
Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN studyHolland C Detke, Peter J Goadsby, Shufang Wang, et al.
Nature Reviews. Neurology|February 15, 2012
Chronic migraine--classification, characteristics and treatmentHans-Christoph Diener, David W Dodick, Peter J Goadsby, et al.
Headache|August 28, 2004
Posterior hypothalamic and brainstem activation in hemicrania continuaManjit S Matharu, Anna S Cohen, David J McGonigle, et al.
Pageof 92

Showing results (701-710 of 916) with videos related to

Sort By:
Pageof 92
BMC Neurology|December 16, 2014
Enhancing cognitive-behavioural therapy for recurrent headache: design of a randomised controlled trialPaul R Martin, Sharon Mackenzie, Siavash Bandarian-Balooch, et al.
Cephalalgia : an International Journal of Headache|March 11, 2015
Is migraine a risk factor for pediatric stroke?Amy A Gelfand, Heather J Fullerton, Alice Jacobson, et al.
British Journal of Pharmacology|January 25, 2020
Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal painChristopher M Holton, Lauren C Strother, Isaac Dripps, et al.
Journal of Patient-Reported Outcomes|December 18, 2024
Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: post hoc analysis of the DELIVER trialPiero Barbanti, Susanne F Awad, Heather Rae-Espinoza, et al.
Headache|June 22, 2019
The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey StudyAmy A Gelfand, Dawn C Buse, Michael D Cabana, et al.
Cephalalgia : an International Journal of Headache|November 1, 1996
Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor geneD R Nyholt, R P Curtain, P T Gaffney, et al.
The Lancet. Neurology|August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trialPeter J Goadsby, David W Dodick, Jessica Ailani, et al.
Neurology|November 18, 2018
Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN studyHolland C Detke, Peter J Goadsby, Shufang Wang, et al.
Nature Reviews. Neurology|February 15, 2012
Chronic migraine--classification, characteristics and treatmentHans-Christoph Diener, David W Dodick, Peter J Goadsby, et al.
Headache|August 28, 2004
Posterior hypothalamic and brainstem activation in hemicrania continuaManjit S Matharu, Anna S Cohen, David J McGonigle, et al.
Pageof 92